Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Ask The Experts Webinar: Clinical Conundrums in LTBI Treatment

Webinar
Ask The Experts Webinar: Clinical Conundrums in LTBI Treatment

A 2-hour webinar covers some common questions around LTBI treatment that may not be addressed in national guidelines, but represent a sample of everyday challenges shared by providers of LTBI care.

Author:

Curry International TB Center, Curry International TB Center

Topic:

Treatment - Latent TB infection (Inactive TB)

Country of Origin:

United States

View Webpage

Related Materials

INH and Rifapentine Treatment for LTBI: Expert Opinions About 3HP Utilization

This webinar includes a panel of experts discussing the questions healthcare providers have about using 3 months of isoniazid and rifapentine once weekly (3HP) to treat latent TB infection (LTBI).

Webinar/Podcast

NTNC Nurses Webinar: Trials, Tribulations and Triumphs with LTBI

This webinar provides information on the identification of patients at high risk for progression to active disease. The presenters also discuss challenges for treatment completion, such as co-morbidities, risky behaviors, and other medications that may interfere with treatment.

Webinar

2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar

The 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis webinar provides an overview of the guidelines development process, key changes in recommendations, and the evidence supporting the changes.

Webinar

Global resources for the prevention,
management, and elimination of TB.